Follow-Up of the Multimodal Treatment Study of Children with ADHD

 
Grant Number: N01MH12012
PI: Karen Wells, PhD (Duke University Medical Center)
Co-I: Jeffery Epstein, PhD

This contract is to follow adolescents with attention deficit hyperactivity disorder (ADHD) who – when they were 7.0 to 9.9 years old – had been randomized into an intensive, 14-month-duration treatment study, the NIMH Multimodal Treatment Study of Children with Attention-Deficit / Hyperactivity Disorder (MTA Study). During the follow-up, the majority of these children will enter and traverse the critical years between 13 and 23 years when ADHD exerts its maximum risks for teenage academic failure, delinquency, substance use and abuse and traffic accidents.